share_log

MediXall Group Receives Full Registered Trademark Status for “Health Karma” (R) From US Patent and Trademark Office

MediXall Group Receives Full Registered Trademark Status for “Health Karma” (R) From US Patent and Trademark Office

MediXall集團從美國專利商標局獲得“Health Karma”(R)的完整註冊商標地位
Accesswire ·  2022/01/05 22:06

FORT LAUDERDALE, FL / ACCESSWIRE / January 5, 2022 / MediXall Group Inc. (OTCQB:MDXL), an innovative healthcare solutions provider, is pleased to announce that on Tuesday, December 14, 2021, the company received full registration of its trademark "Health Karma"® with the U.S. Patent and Trademark Office.

佛羅裏達州勞德爾達爾堡/ACCESSWIRE/2022年1月5日/MediXall Group Inc.(場外交易市場代碼:MDXL)創新的醫療保健解決方案提供商,很高興地宣佈,2021年12月14日(星期二),該公司獲得了其商標“Health Karma”®在美國專利商標局的正式註冊。

"Health Karma is redefining the benefits landscape for people both with and without traditional health insurance," said Health Karma CEO, Travis Jackson. "This trademark will enable us to further strengthen our name as the go-to healthcare hub that helps Americans save thousands of dollars on their healthcare, regardless of their health insurance coverage. Our promise is simple: we want people to improve their healthcare access while reducing what they pay for it."

“健康業力正在重新定義有沒有傳統醫療保險的人的利益格局,”他説。Health Karma首席執行官特拉維斯·傑克遜。“這一商標將使我們能夠進一步鞏固我們作為首選醫療中心的形象,幫助美國人在醫療保健上節省數千美元,無論他們的醫療保險覆蓋範圍如何。我們的承諾很簡單:我們希望人們改善醫療保健的可及性,同時降低他們支付的費用。”

Neil Swartz, Chairman of MediXall Group stated "From day one, our goal at MediXall Group has been to take the complexity out of healthcare. Our first-generation technology was designed to make shopping for healthcare as easy as booking a flight or hotel on Priceline or Expedia.

MediXall集團董事長尼爾·斯沃茨(Neil Swartz)表示從第一天起,我們在MediXall集團的目標就是消除醫療保健的複雜性。我們的第一代技術旨在使醫療保健購物像在Priceline或Expedia上預訂機票或酒店一樣容易。

With our second-generation platform, Health Karma®, we've built on top of our foundation to create a place where people can find and access the educational tips, tools, and guidance needed to take the hassle out of managing their healthcare, while saving them time and money in the process."

有了我們的第二代平臺,健康業力®,我們已經在我們的基礎上建立了一個地方,人們可以在這裏找到和獲得所需的教育提示、工具和指導,以消除管理醫療保健的麻煩,同時在這個過程中節省他們的時間和金錢。“

The Health Karma® trademark was granted USPTO Registration Number 6585718.

Health Karma®商標被授予美國專利商標局註冊號6585718。

For more information on Health Karma, visit their official website: and follow @HealthKarmaApp on Facebook, Instagram, and Twitter.

有關以下內容的更多信息:健康因果報應,請訪問他們的官方網站:並關注@HealthKarmaApp在臉書,Instagram和推特上。

About MediXall Group, Inc.

MediXall集團公司簡介

MediXall Group, Inc. (OTCQB:MDXL) is a technology and innovation-driven organization purposefully designed and structured around delivering products and services to make it easier for consumers to learn, decide and pay for healthcare. The mission of MediXall Group is to revolutionize the healthcare industry by improving communication; providing better technology and support services; and enabling more efficient, cost-effective healthcare for the consumer. By approaching the entire healthcare ecosystem, MediXall creates, invests, and incubates companies that embody its mission statement.

MediXall Group,Inc.(場外交易市場代碼:MDXL)是一家技術和創新驅動型組織,旨在圍繞提供產品和服務進行設計和構建,使消費者更容易瞭解、決定和支付醫療保健費用。MediXall集團的使命是通過改善通信、提供更好的技術和支持服務以及為消費者提供更高效、更具成本效益的醫療保健來徹底改變醫療保健行業。通過接近整個醫療生態系統,MediXall創建、投資和孵化體現其使命宣言的公司。

About Health Karma, Inc.

關於Health Karma公司

Health Karma, a wholly owned subsidiary of MediXall Group, is a data-driven healthcare technology company that is on a mission to continually raise the bar of the healthcare experience by empowering people to understand and manage their entire health care journey anywhere, anytime, whether they have insurance or not. For more information, please visit .

Health Karma是MediXall集團的全資子公司,是一家數據驅動型醫療保健技術公司,其使命是通過使人們能夠隨時隨地瞭解和管理他們的整個醫療保健旅程,而無論他們是否有保險,從而不斷提高醫療保健體驗的門檻。有關更多信息,請訪問。

Safe Harbor Statement

安全港聲明

This press release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. These forward-looking statements are based on current plans and expectations of management and are subject to a number of uncertainties and risks that could significantly affect the company's current plans and expectations, as well as future results of operations and financial condition. Specifically, the company's ability to raise additional capital, execute its business plan and strategy, sustain, or increase gross margins, achieve profitability, and build shareholder value are forward-looking statements. A more extensive listing of risks and factors that may affect the company's business prospects and cause actual results to differ materially from those described in the forward-looking statements can be found in the reports and other documents filed by the company with the Securities and Exchange Commission. The company undertakes no obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future events or otherwise.

本新聞稿包含1933年“證券法”第27A節和1934年“證券交易法”第21E節所指的前瞻性陳述。這些前瞻性陳述基於管理層當前的計劃和預期,可能會受到一些不確定性和風險的影響,這些不確定性和風險可能會對公司當前的計劃和預期以及未來的經營結果和財務狀況產生重大影響。具體地説,公司籌集額外資本、執行業務計劃和戰略、維持或提高毛利率、實現盈利和創造股東價值的能力都是前瞻性表述。在公司提交給證券交易委員會的報告和其他文件中可以找到更廣泛的風險和因素清單,這些風險和因素可能會影響公司的業務前景,導致實際結果與前瞻性陳述中描述的大不相同。公司不承擔公開更新或修改任何前瞻性陳述的義務,無論是由於新信息、未來事件還是其他原因。

Investor Relations Contact: (954) 653-8216

投資者關係聯繫人:(954) 653-8216

Media Contact: Karla Hernandez, karla@transmediagroup.com, (561) 750-9800

媒體聯繫人:Karla Hernandez,Karla@transmediagroup.com,(561)750-9800

SOURCE: MediXall Group, Inc.

資料來源:MediXall集團,Inc.


View source version on accesswire.com:
在accesswire.com上查看源代碼版本:

譯文內容由第三人軟體翻譯。


以上內容僅用作資訊或教育之目的,不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。
    搶先評論